Partners Matt Riordan and Domenick Bertelli were guest lecturers at the Harvard Medical School course on Healthcare, Innovation, and Commercialization (HIC) on September 18. The session focused on market sizing and pricing new innovations, drawing on several dozen outside-in case studies Putnam has built over the years in the context of firm knowledge-development. For nearly a decade, HIC has offered aspiring scientists and physicians education and hands-on training to help translate innovative research emerging from Harvard labs into meaningful commercial opportunities. Putnam has helped support the program since 2013, over which time more than 500 students have gone through course. Other weekly modules address different aspects of the commercialization process, such as intellectual property and FDA regulation. Students are also assigned a team project to develop a business pitch for a Harvard OTD-based technology.
The course culminates with Innovation Day in November, which features live business plan pitches to real investors and a panel of expert judges, including several Putnam partners and principals.